US 12247213
Treatment of mucopolysaccharidosis IVA
granted A61KA61K38/00A61K48/0058
Quick answer
US patent 12247213 (Treatment of mucopolysaccharidosis IVA) held by REGENXBIO INC. expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENXBIO INC.
- Grant date
- Tue Mar 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K38/00, A61K48/0058, A61P, A61P19/00